 | • レポートコード：GIR-107A14406 • 出版社/出版日：GlobalInfoResearch / 2021年7月20日 • レポート形態：英文、PDF、78ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、オーロラキナーゼCのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オーロラキナーゼCの種類別市場規模（AMG-900、Danusertib、Ilorasertib、NMI-900、SAR-156497、その他）、用途別市場規模（固形腫瘍、非小細胞肺がん、急性リンパ性白血病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・オーロラキナーゼCの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AbbVie Inc、Amgen Inc、Cielo Therapeutics Inc、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：AMG-900、Danusertib、Ilorasertib、NMI-900、SAR-156497、その他 ・用途別分析2016年-2026年：固形腫瘍、非小細胞肺がん、急性リンパ性白血病、その他 ・オーロラキナーゼCの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・オーロラキナーゼCのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・オーロラキナーゼCのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オーロラキナーゼCの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・オーロラキナーゼCの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Aurora Kinase C market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Aurora Kinase C size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Aurora Kinase C market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Aurora Kinase C market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
AMG-900
Danusertib
Ilorasertib
NMI-900
SAR-156497
Others
Market segment by Application can be divided into
Solid Tumor
Non-Small Cell Lung Cancer
Acute Lymphocytic Leukemia
Others
The key market players for global Aurora Kinase C market are listed below:
AbbVie Inc
Amgen Inc
Cielo Therapeutics Inc
Sanofi
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Aurora Kinase C product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Aurora Kinase C, with price, sales, revenue and global market share of Aurora Kinase C from 2019 to 2021.
Chapter 3, the Aurora Kinase C competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aurora Kinase C breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Aurora Kinase C market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Aurora Kinase C sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Aurora Kinase C Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Aurora Kinase C Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 AMG-900
1.2.3 Danusertib
1.2.4 Ilorasertib
1.2.5 NMI-900
1.2.6 SAR-156497
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Aurora Kinase C Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Solid Tumor
1.3.3 Non-Small Cell Lung Cancer
1.3.4 Acute Lymphocytic Leukemia
1.3.5 Others
1.4 Global Aurora Kinase C Market Size & Forecast
1.4.1 Global Aurora Kinase C Sales in Value (2016-2026))
1.4.2 Global Aurora Kinase C Sales in Volume (2016-2026)
1.4.3 Global Aurora Kinase C Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Aurora Kinase C Production Capacity Analysis
1.5.1 Global Aurora Kinase C Total Production Capacity (2016-2026)
1.5.2 Global Aurora Kinase C Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Aurora Kinase C Market Drivers
1.6.2 Aurora Kinase C Market Restraints
1.6.3 Aurora Kinase C Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie Inc
2.1.1 AbbVie Inc Details
2.1.2 AbbVie Inc Major Business
2.1.3 AbbVie Inc Aurora Kinase C Product and Services
2.1.4 AbbVie Inc Aurora Kinase C Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Amgen Inc
2.2.1 Amgen Inc Details
2.2.2 Amgen Inc Major Business
2.2.3 Amgen Inc Aurora Kinase C Product and Services
2.2.4 Amgen Inc Aurora Kinase C Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Cielo Therapeutics Inc
2.3.1 Cielo Therapeutics Inc Details
2.3.2 Cielo Therapeutics Inc Major Business
2.3.3 Cielo Therapeutics Inc Aurora Kinase C Product and Services
2.3.4 Cielo Therapeutics Inc Aurora Kinase C Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Aurora Kinase C Product and Services
2.4.4 Sanofi Aurora Kinase C Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Aurora Kinase C Sales by Manufacturer
3.1 Global Aurora Kinase C Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Aurora Kinase C Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Aurora Kinase C
3.4 Market Concentration Rate
3.4.1 Top 3 Aurora Kinase C Manufacturer Market Share
3.4.2 Top 6 Aurora Kinase C Manufacturer Market Share
3.5 Global Aurora Kinase C Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Aurora Kinase C Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Aurora Kinase C Market Size by Region
4.1.1 Global Aurora Kinase C Sales in Volume by Region (2016-2026)
4.1.2 Global Aurora Kinase C Revenue by Region (2016-2026)
4.2 North America Aurora Kinase C Revenue (2016-2026)
4.3 Europe Aurora Kinase C Revenue (2016-2026)
4.4 Asia-Pacific Aurora Kinase C Revenue (2016-2026)
4.5 South America Aurora Kinase C Revenue (2016-2026)
4.6 Middle East and Africa Aurora Kinase C Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Aurora Kinase C Sales in Volume by Type (2016-2026)
5.2 Global Aurora Kinase C Revenue by Type (2016-2026)
5.3 Global Aurora Kinase C Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Aurora Kinase C Sales in Volume by Application (2016-2026)
6.2 Global Aurora Kinase C Revenue by Application (2016-2026)
6.3 Global Aurora Kinase C Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Aurora Kinase C Sales by Type (2016-2026)
7.2 North America Aurora Kinase C Sales by Application (2016-2026)
7.3 North America Aurora Kinase C Market Size by Country
7.3.1 North America Aurora Kinase C Sales in Volume by Country (2016-2026)
7.3.2 North America Aurora Kinase C Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Aurora Kinase C Sales by Type (2016-2026)
8.2 Europe Aurora Kinase C Sales by Application (2016-2026)
8.3 Europe Aurora Kinase C Market Size by Country
8.3.1 Europe Aurora Kinase C Sales in Volume by Country (2016-2026)
8.3.2 Europe Aurora Kinase C Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Aurora Kinase C Sales by Type (2016-2026)
9.2 Asia-Pacific Aurora Kinase C Sales by Application (2016-2026)
9.3 Asia-Pacific Aurora Kinase C Market Size by Region
9.3.1 Asia-Pacific Aurora Kinase C Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Aurora Kinase C Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Aurora Kinase C Sales by Type (2016-2026)
10.2 South America Aurora Kinase C Sales by Application (2016-2026)
10.3 South America Aurora Kinase C Market Size by Country
10.3.1 South America Aurora Kinase C Sales in Volume by Country (2016-2026)
10.3.2 South America Aurora Kinase C Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Aurora Kinase C Sales by Type (2016-2026)
11.2 Middle East & Africa Aurora Kinase C Sales by Application (2016-2026)
11.3 Middle East & Africa Aurora Kinase C Market Size by Country
11.3.1 Middle East & Africa Aurora Kinase C Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Aurora Kinase C Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Aurora Kinase C Typical Distributors
12.3 Aurora Kinase C Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Aurora Kinase C Revenue by Type, (USD Million), 2021-2026
Table 2. Global Aurora Kinase C Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Inc Major Business
Table 5. AbbVie Inc Aurora Kinase C Product and Services
Table 6. AbbVie Inc Aurora Kinase C Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Inc Major Business
Table 9. Amgen Inc Aurora Kinase C Product and Services
Table 10. Amgen Inc Aurora Kinase C Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cielo Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 12. Cielo Therapeutics Inc Major Business
Table 13. Cielo Therapeutics Inc Aurora Kinase C Product and Services
Table 14. Cielo Therapeutics Inc Aurora Kinase C Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Aurora Kinase C Product and Services
Table 18. Sanofi Aurora Kinase C Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Aurora Kinase C Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 20. Global Aurora Kinase C Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Aurora Kinase C, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Aurora Kinase C Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 23. Head Office and Aurora Kinase C Production Site of Key Manufacturer
Table 24. Aurora Kinase C New Entrant and Capacity Expansion Plans
Table 25. Aurora Kinase C Mergers & Acquisitions in the Past Five Years
Table 26. Global Aurora Kinase C Sales by Region (2016-2021e) & (K Pcs)
Table 27. Global Aurora Kinase C Sales by Region (2021-2026) & (K Pcs)
Table 28. Global Aurora Kinase C Revenue by Region (2016-2021e) & (USD Million)
Table 29. Global Aurora Kinase C Revenue by Region (2021-2026) & (USD Million)
Table 30. Global Aurora Kinase C Sales by Type (2016-2021e) & (K Pcs)
Table 31. Global Aurora Kinase C Sales by Type (2021-2026) & (K Pcs)
Table 32. Global Aurora Kinase C Revenue by Type (2016-2021e) & (USD Million)
Table 33. Global Aurora Kinase C Revenue by Type (2021-2026) & (USD Million)
Table 34. Global Aurora Kinase C Price by Type (2016-2021e) & (USD/Pcs)
Table 35. Global Aurora Kinase C Price by Type (2021-2026) & (USD/Pcs)
Table 36. Global Aurora Kinase C Sales by Application (2016-2021e) & (K Pcs)
Table 37. Global Aurora Kinase C Sales by Application (2021-2026) & (K Pcs)
Table 38. Global Aurora Kinase C Revenue by Application (2016-2021e) & (USD Million)
Table 39. Global Aurora Kinase C Revenue by Application (2021-2026) & (USD Million)
Table 40. Global Aurora Kinase C Price by Application (2016-2021e) & (USD/Pcs)
Table 41. Global Aurora Kinase C Price by Application (2021-2026) & (USD/Pcs)
Table 42. North America Aurora Kinase C Sales by Country (2016-2021e) & (K Pcs)
Table 43. North America Aurora Kinase C Sales by Country (2021-2026) & (K Pcs)
Table 44. North America Aurora Kinase C Revenue by Country (2016-2021e) & (USD Million)
Table 45. North America Aurora Kinase C Revenue by Country (2021-2026) & (USD Million)
Table 46. North America Aurora Kinase C Sales by Type (2016-2021e) & (K Pcs)
Table 47. North America Aurora Kinase C Sales by Type (2021-2026) & (K Pcs)
Table 48. North America Aurora Kinase C Sales by Application (2016-2021e) & (K Pcs)
Table 49. North America Aurora Kinase C Sales by Application (2021-2026) & (K Pcs)
Table 50. Europe Aurora Kinase C Sales by Country (2016-2021e) & (K Pcs)
Table 51. Europe Aurora Kinase C Sales by Country (2021-2026) & (K Pcs)
Table 52. Europe Aurora Kinase C Revenue by Country (2016-2021e) & (USD Million)
Table 53. Europe Aurora Kinase C Revenue by Country (2021-2026) & (USD Million)
Table 54. Europe Aurora Kinase C Sales by Type (2016-2021e) & (K Pcs)
Table 55. Europe Aurora Kinase C Sales by Type (2021-2026) & (K Pcs)
Table 56. Europe Aurora Kinase C Sales by Application (2016-2021e) & (K Pcs)
Table 57. Europe Aurora Kinase C Sales by Application (2021-2026) & (K Pcs)
Table 58. Asia-Pacific Aurora Kinase C Sales by Region (2016-2021e) & (K Pcs)
Table 59. Asia-Pacific Aurora Kinase C Sales by Region (2021-2026) & (K Pcs)
Table 60. Asia-Pacific Aurora Kinase C Revenue by Region (2016-2021e) & (USD Million)
Table 61. Asia-Pacific Aurora Kinase C Revenue by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific Aurora Kinase C Sales by Type (2016-2021e) & (K Pcs)
Table 63. Asia-Pacific Aurora Kinase C Sales by Type (2021-2026) & (K Pcs)
Table 64. Asia-Pacific Aurora Kinase C Sales by Application (2016-2021e) & (K Pcs)
Table 65. Asia-Pacific Aurora Kinase C Sales by Application (2021-2026) & (K Pcs)
Table 66. South America Aurora Kinase C Sales by Country (2016-2021e) & (K Pcs)
Table 67. South America Aurora Kinase C Sales by Country (2021-2026) & (K Pcs)
Table 68. South America Aurora Kinase C Revenue by Country (2016-2021e) & (USD Million)
Table 69. South America Aurora Kinase C Revenue by Country (2021-2026) & (USD Million)
Table 70. South America Aurora Kinase C Sales by Type (2016-2021e) & (K Pcs)
Table 71. South America Aurora Kinase C Sales by Type (2021-2026) & (K Pcs)
Table 72. South America Aurora Kinase C Sales by Application (2016-2021e) & (K Pcs)
Table 73. South America Aurora Kinase C Sales by Application (2021-2026) & (K Pcs)
Table 74. Middle East & Africa Aurora Kinase C Sales by Country (2016-2021e) & (K Pcs)
Table 75. Middle East & Africa Aurora Kinase C Sales by Country (2021-2026) & (K Pcs)
Table 76. Middle East & Africa Aurora Kinase C Revenue by Country (2016-2021e) & (USD Million)
Table 77. Middle East & Africa Aurora Kinase C Revenue by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa Aurora Kinase C Sales by Type (2016-2021e) & (K Pcs)
Table 79. Middle East & Africa Aurora Kinase C Sales by Type (2021-2026) & (K Pcs)
Table 80. Middle East & Africa Aurora Kinase C Sales by Application (2016-2021e) & (K Pcs)
Table 81. Middle East & Africa Aurora Kinase C Sales by Application (2021-2026) & (K Pcs)
Table 82. Direct Channel Pros & Cons
Table 83. Indirect Channel Pros & Cons
Table 84. Aurora Kinase C Typical Distributors
Table 85. Aurora Kinase C Typical Customers
List of Figures
Figure 1. Aurora Kinase C Picture
Figure 2. Global Aurora Kinase C Sales Market Share by Type in 2020
Figure 3. AMG-900
Figure 4. Danusertib
Figure 5. Ilorasertib
Figure 6. NMI-900
Figure 7. SAR-156497
Figure 8. Others
Figure 9. Global Aurora Kinase C Sales Market Share by Application in 2020
Figure 10. Solid Tumor
Figure 11. Non-Small Cell Lung Cancer
Figure 12. Acute Lymphocytic Leukemia
Figure 13. Others
Figure 14. Global Aurora Kinase C Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Aurora Kinase C Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Aurora Kinase C Sales (2016-2026) & (K Pcs)
Figure 17. Global Aurora Kinase C Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Aurora Kinase C Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Aurora Kinase C Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Aurora Kinase C Market Drivers
Figure 21. Aurora Kinase C Market Restraints
Figure 22. Aurora Kinase C Market Trends
Figure 23. Global Aurora Kinase C Sales Market Share by Manufacturer in 2020
Figure 24. Global Aurora Kinase C Revenue Market Share by Manufacturer in 2020
Figure 25. Aurora Kinase C Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Aurora Kinase C Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Aurora Kinase C Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Aurora Kinase C Sales Market Share by Region (2016-2026)
Figure 29. Global Aurora Kinase C Revenue Market Share by Region (2016-2026)
Figure 30. North America Aurora Kinase C Revenue (2016-2026) & (USD Million)
Figure 31. Europe Aurora Kinase C Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Aurora Kinase C Revenue (2016-2026) & (USD Million)
Figure 33. South America Aurora Kinase C Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Aurora Kinase C Revenue (2016-2026) & (USD Million)
Figure 35. Global Aurora Kinase C Sales Market Share by Type (2016-2026)
Figure 36. Global Aurora Kinase C Revenue Market Share by Type (2016-2026)
Figure 37. Global Aurora Kinase C Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Aurora Kinase C Sales Market Share by Application (2016-2026)
Figure 39. Global Aurora Kinase C Revenue Market Share by Application (2016-2026)
Figure 40. Global Aurora Kinase C Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Aurora Kinase C Sales Market Share by Type (2016-2026)
Figure 42. North America Aurora Kinase C Sales Market Share by Application (2016-2026)
Figure 43. North America Aurora Kinase C Sales Market Share by Country (2016-2026)
Figure 44. North America Aurora Kinase C Revenue Market Share by Country (2016-2026)
Figure 45. United States Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Aurora Kinase C Sales Market Share by Type (2016-2026)
Figure 49. Europe Aurora Kinase C Sales Market Share by Application (2016-2026)
Figure 50. Europe Aurora Kinase C Sales Market Share by Country (2016-2026)
Figure 51. Europe Aurora Kinase C Revenue Market Share by Country (2016-2026)
Figure 52. Germany Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Aurora Kinase C Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Aurora Kinase C Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Aurora Kinase C Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Aurora Kinase C Revenue Market Share by Region (2016-2026)
Figure 61. China Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Aurora Kinase C Sales Market Share by Type (2016-2026)
Figure 68. South America Aurora Kinase C Sales Market Share by Application (2016-2026)
Figure 69. South America Aurora Kinase C Sales Market Share by Country (2016-2026)
Figure 70. South America Aurora Kinase C Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Aurora Kinase C Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Aurora Kinase C Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Aurora Kinase C Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Aurora Kinase C Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Aurora Kinase C Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source